期刊文献+

卡马西平不良反应 被引量:2

原文传递
导出
出处 《中国误诊学杂志》 CAS 2009年第22期5529-5530,共2页 Chinese Journal of Misdiagnostics
  • 相关文献

参考文献5

二级参考文献21

  • 1牛红喜,耿龙,尚英彬,徐媛媛,宋芳吉,陈洪铎.191例重症药疹临床分析[J].中华皮肤科杂志,2006,39(9):530-532. 被引量:26
  • 2范洪斌.卡马西平药疹26例临床分析[J].皮肤病与性病,1996,18(4):14-14. 被引量:9
  • 3张强,孙道开.卡马西平致药源性皮肤及肝脏损害2例报告[J].中国实用儿科杂志,1997,12(2):124-124. 被引量:6
  • 4许晨.卡马西平治疗相关性白血病2例[J].白血病淋巴瘤,1999,8(1):30-30.
  • 5黄生万.卡马西平致血小板减少2例报告[J].临床脑电学杂志,1995,4(3):176-176.
  • 6李家泰.临床药理学[M].北京:人民卫生出版社,1998.901-902.
  • 7Hashimoto K, Yasukawa M, Tohygama M. Human herpesvirus 6 and drug allerge[J]. Curt. Opin Allergy Clin Immunol, 2003, 3 (4) :255 -260.
  • 8Lown KS, Thunnel KE, Benedict PE, et al. The erythromycin breath test predicts the clearance of midazolam [ J ]. Clin Pharmacol Ther, 1995; 57(1) :16 -24.
  • 9Turgeon DK, Normolle DP, Leichtman AB, et al. Erythromycin breath test predicts oral clearance of cyclosporine in kidney transplant recipients[J]. Clin Pharmacol Ther, 1992; 52(5) :471 - 478.
  • 10Kerr BM, Thummel KE, Wurden C J, et al. Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11 -epoxide formation. Biochem Pharmacol [ J]. 1994 Jun 1 ; 47 ( 11 ) : 1969 - 1979.

共引文献13

同被引文献18

  • 1石奕武,廖卫平.抗癫痫药物引起的Stevens-Johnson综合症与HLA-B*1502[J].重庆医科大学学报,2008,33(z1):94-95. 被引量:5
  • 2Chung WH,Hung SI,Hong HS,et al.Medical genetics:a marker for Stevens-Johnson syndrome[J].Nature,2004,428(6892):486.
  • 3Ueta M,Sotozono C,Tokunaga K,et al.Strong Association Between HLA-A*0206and Stevens-Johnson Syndrome in the Japanese[J].Am J Ophthalmol,2007,143(2):367-368.
  • 4Hunga SI,Chungb WH,Jee SH,et al.Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions[J].Pharmacogenet Genomics,2006,16(4):297-306.
  • 5Man CB,Kwan P,Baum L,et al.Association between HLA-B*1502Allele and Antiepileptic Drug-Induced Cutaneous Reactions in Han Chinese[J].Epilepsia,2007,48(5):1015-1018.
  • 6Locharernkul C,Loplumlert J,Limotai C,et al.Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502allele in Thai Population[J].Epilepsia,2008,49(12):2087-2091.
  • 7Mehta TY,Prajapati1LM,Mittal B,et al.Association of HLA-B*1502allele and carbamazepine-induced Stevens-Johnson syn-drome among Indians[J].Indian J Dermatol Venereol Leprol,2009,75(6):578-582.
  • 8Tassaneeyakul W,STiamkao,Jantararoungtong T,et al.Association between HLA-B*1502and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population[J].Epilep-sia,2010,51(5):926-930.
  • 9Wu XT,Hu FY,An DM,et al.Association between carba-mazepine-induced cutaneous adverse drug reactions and the HLA-B*1502allele among patients in central China[J].Epilep-sy Behav,2010,19(3):405-408.
  • 10Chang CC,Too CL,Murad S,et al.Association of HLA-B*1502allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population[J].Int J Dermatol,2011,50(5):221-224.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部